An infant named KJ has made history as the first patient to be treated with an in vivo CRISPR gene editing therapy designed ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of ...

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

The Garden State is looking to grow into the next big biotech hub. | The Garden State is looking to grow into the next big ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

Biohaven is giving investors whiplash. Forty-eight hours after saying its filing was on track, the biopharma revealed the FDA ...

In its yearly survey of international clinicians and patients, Philips illustrated significant gaps in people’s trust when it ...